Vaupel P - Search Results

1

Adjuvant temozolomide-based chemoradiotherapy versus radiotherapy alone in patients with WHO III astrocytoma: The Mainz experience.

Mayer A, Schwanbeck C, Sommer C, Stockinger M, Giese A, Renovanz M, Vaupel P, Schmidberger H. Mayer A, et al. Among authors: vaupel p. Strahlenther Onkol. 2015 Aug;191(8):665-71. doi: 10.1007/s00066-015-0855-x. Epub 2015 May 30. Strahlenther Onkol. 2015. PMID: 26025143

2

Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme.

Mayer A, Vaupel P, Struss HG, Giese A, Stockinger M, Schmidberger H. Mayer A, et al. Among authors: vaupel p. Strahlenther Onkol. 2014 Oct;190(10):933-8. doi: 10.1007/s00066-014-0696-z. Epub 2014 Jun 18. Strahlenther Onkol. 2014. PMID: 24938515

3

Response to commentary by Champ and Klement: Is a ketogenic diet the solution for the hyperglycemia problem in glioblastoma therapy?

Mayer A, Vaupel P, Struss HG, Giese A, Stockinger M, Schmidberger H. Mayer A, et al. Among authors: vaupel p. Strahlenther Onkol. 2015 Mar;191(3):283-4. doi: 10.1007/s00066-014-0793-z. Strahlenther Onkol. 2015. PMID: 25595495 No abstract available.

4

Inclusion of PET-CT into planning of primary or neoadjuvant chemoradiotherapy of esophageal cancer improves prognosis.

Metzger JC, Wollschläger D, Miederer M, Vaupel P, Moehler M, Schmidberger H, Mayer A. Metzger JC, et al. Among authors: vaupel p. Strahlenther Onkol. 2017 Oct;193(10):791-799. doi: 10.1007/s00066-017-1164-3. Epub 2017 Aug 2. Strahlenther Onkol. 2017. PMID: 28770295 English.

5

Oxygenation status of gynecologic tumors: what is the optimal hemoglobin level?

Vaupel P, Thews O, Mayer A, Höckel S, Höckel M. Vaupel P, et al. Strahlenther Onkol. 2002 Dec;178(12):727-31. doi: 10.1007/s00066-002-1081-x. Strahlenther Onkol. 2002. PMID: 12491062

6

Impact of hemoglobin levels on tumor oxygenation: the higher, the better?

Vaupel P, Mayer A, Höckel M. Vaupel P, et al. Strahlenther Onkol. 2006 Feb;182(2):63-71. doi: 10.1007/s00066-006-1543-7. Strahlenther Onkol. 2006. PMID: 16447012 Review.

7

Endogenous hypoxia markers in locally advanced cancers of the uterine cervix: reality or wishful thinking?

Mayer A, Höckel M, Vaupel P. Mayer A, et al. Among authors: vaupel p. Strahlenther Onkol. 2006 Sep;182(9):501-10. doi: 10.1007/s00066-006-1525-9. Strahlenther Onkol. 2006. PMID: 16944371 Review.

8

Hypoxia in cancer: significance and impact on clinical outcome.

Vaupel P, Mayer A. Vaupel P, et al. Cancer Metastasis Rev. 2007 Jun;26(2):225-39. doi: 10.1007/s10555-007-9055-1. Cancer Metastasis Rev. 2007. PMID: 17440684 Review.

9

Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma.

Mayer A, Schneider F, Vaupel P, Sommer C, Schmidberger H. Mayer A, et al. Among authors: vaupel p. Int J Oncol. 2012 Oct;41(4):1260-70. doi: 10.3892/ijo.2012.1555. Epub 2012 Jul 16. Int J Oncol. 2012. PMID: 22825389 Free PMC article.

10

Hypoxia, lactate accumulation, and acidosis: siblings or accomplices driving tumor progression and resistance to therapy?

Mayer A, Vaupel P. Mayer A, et al. Among authors: vaupel p. Adv Exp Med Biol. 2013;789:203-209. doi: 10.1007/978-1-4614-7411-1_28. Adv Exp Med Biol. 2013. PMID: 23852496 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

411 results

Search Page

Filters